We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Staccato Prochlorperazine Single Dose PK

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00610727
Recruitment Status : Completed
First Posted : February 8, 2008
Last Update Posted : April 29, 2009
Information provided by:
Alexza Pharmaceuticals, Inc.

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Primary Completion Date : October 2004
  Study Completion Date : October 2004

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 March 10, 2017 April 19, 2017
2 June 18, 2017 January 25, 2018
3 January 26, 2018